VG
Valerio Giovanni Vaccarone
About Valerio Giovanni Vaccarone
Data last updated:
Valerio Giovanni Vaccarone is a Director at Diasorin Healthcare India Private Limited (since 2023). The company operates in Chemicals and Materials. Diasorin Healthcare India Private Limited reported revenue of ₹64.18 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Diasorin Healthcare India Private Limited U85100MH2012FTC323879 | Director | 02 Mar 2023 | 2012 | ₹64.18 Cr (FY 2025) | Active |
Board colleagues of Valerio Giovanni Vaccarone
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankit Kumar Jain | Diasorin Healthcare India Private Limited | Company Secretary | |
| John Alexander Hoffarth | 08734737 | Diasorin Healthcare India Private Limited | Director |
| Joshua Glason | 10052715 | Diasorin Healthcare India Private Limited | Director |
| Prem Kumar Charles | 10639781 | Diasorin Healthcare India Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Valerio Giovanni Vaccarone
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valerio Giovanni Vaccarone
Valerio Giovanni Vaccarone currently holds 1 directorship: Diasorin Healthcare India Private Limited (Director, since 02 Mar 2023, revenue ₹64.18 Cr (FY 2025)).
Valerio Giovanni Vaccarone was first appointed on 02 Mar 2023 as Director at Diasorin Healthcare India Private Limited.
The current boards of Valerio Giovanni Vaccarone's companies include Ankit Kumar Jain (Diasorin Healthcare India Private Limited), John Alexander Hoffarth (Diasorin Healthcare India Private Limited), Joshua Glason (Diasorin Healthcare India Private Limited), Prem Kumar Charles (Diasorin Healthcare India Private Limited).